(Q48734318)

15 February 2018

title

Short course radiotherapy is an appropriate option for most malignant glioma patients. (English)

1 reference

15 February 2018

Adaptive radiation therapy

main subject

0 references

author name string

Kleinberg L

1

1 reference

15 February 2018

Slick T

2

1 reference

15 February 2018

Enger C

3

1 reference

15 February 2018

Grossman S

4

1 reference

15 February 2018

Brem H

5

1 reference

15 February 2018

Wharam MD Jr

6

1 reference

15 February 2018

language of work or name

English

0 references

publication date

1 April 1997

1 reference

15 February 2018

International Journal of Radiation Oncology Biology Physics

published in

1 reference

15 February 2018

volume

38

1 reference

15 February 2018

issue

1

1 reference

15 February 2018

page(s)

31-36

1 reference

15 February 2018

A prospective study of short-course radiotherapy in poor prognosis glioblastoma multiforme.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900222-8

7 January 2021

Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900222-8

7 January 2021

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900222-8

7 January 2021

A randomized trial of accelerated hyperfractionated radiation therapy and bis-chloroethyl nitrosourea for malignant glioma. A preliminary report of Radiation Therapy Oncology Group 83-02

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900222-8

7 January 2021

Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900222-8

7 January 2021

Accelerated fractionation radiotherapy for hospitalized glioblastoma multiforme patients with poor prognostic factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900222-8

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900222-8

7 January 2021

Treatment of supratentorial high grade gliomas with split course high fractional dose postoperative radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900222-8

7 January 2021

Cerebral radionecrosis: Incidence and risk in relation to dose, time, fractionation and volume

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900222-8

7 January 2021

A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery: final report of an RTOG study.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900222-8

7 January 2021

Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma--possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: report of the Radiation Therapy Oncology Group Protocol 8302.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900222-8

7 January 2021

Glioblastoma in the older patient: how long a course of radiotherapy is necessary?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900222-8

7 January 2021

Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900222-8

7 January 2021

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900222-8

7 January 2021

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900222-8

7 January 2021

10.1016/S0360-3016(97)00222-8

Identifiers

DOI

1 reference

15 February 2018

1 reference

15 February 2018